[English] 日本語
Yorodumi- EMDB-18541: Structure of the mu opioid receptor bound to the antagonist nanob... -
+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-18541 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of the mu opioid receptor bound to the antagonist nanobody NbE | ||||||||||||
Map data | DeepEMhancer sharpened map of the MOR_NbE_NabFab_anti-Fab complex. | ||||||||||||
Sample |
| ||||||||||||
Keywords | opioid receptor / nanobody / antagonist / NabFab / MOR / MEMBRANE PROTEIN | ||||||||||||
Function / homology | Function and homology information Opioid Signalling / spine apparatus / beta-endorphin receptor activity / morphine receptor activity / negative regulation of Wnt protein secretion / Peptide ligand-binding receptors / adenylate cyclase-inhibiting opioid receptor signaling pathway / positive regulation of appetite / G-protein activation / G protein-coupled opioid receptor activity ...Opioid Signalling / spine apparatus / beta-endorphin receptor activity / morphine receptor activity / negative regulation of Wnt protein secretion / Peptide ligand-binding receptors / adenylate cyclase-inhibiting opioid receptor signaling pathway / positive regulation of appetite / G-protein activation / G protein-coupled opioid receptor activity / negative regulation of luteinizing hormone secretion / G protein-coupled opioid receptor signaling pathway / sperm ejaculation / G alpha (i) signalling events / adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway / negative regulation of nitric oxide biosynthetic process / negative regulation of cAMP-mediated signaling / negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway / neuropeptide binding / regulation of NMDA receptor activity / positive regulation of neurogenesis / eating behavior / negative regulation of cytosolic calcium ion concentration / transmission of nerve impulse / social behavior / neuropeptide signaling pathway / G-protein alpha-subunit binding / voltage-gated calcium channel activity / GABA-ergic synapse / positive regulation of gluconeogenesis / dendrite membrane / sensory perception of pain / presynaptic modulation of chemical synaptic transmission / dendrite cytoplasm / adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway / excitatory postsynaptic potential / locomotory behavior / G protein-coupled receptor activity / adenylate cyclase-activating dopamine receptor signaling pathway / G-protein beta-subunit binding / presynaptic membrane / phospholipase C-activating G protein-coupled receptor signaling pathway / perikaryon / postsynaptic membrane / response to ethanol / positive regulation of ERK1 and ERK2 cascade / endosome / neuron projection / G protein-coupled receptor signaling pathway / protein domain specific binding / axon / focal adhesion / dendrite / membrane / plasma membrane Similarity search - Function | ||||||||||||
Biological species | Mus musculus (house mouse) / Lama glama (llama) / synthetic construct (others) | ||||||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.2 Å | ||||||||||||
Authors | Yu J / Kumar A / Zhang X / Martin C / Raia P / Manglik A / Ballet S / Boland A / Stoeber M | ||||||||||||
Funding support | Switzerland, 3 items
| ||||||||||||
Citation | Journal: bioRxiv / Year: 2023 Title: Structural Basis of μ-Opioid Receptor-Targeting by a Nanobody Antagonist. Authors: Jun Yu / Amit Kumar / Xuefeng Zhang / Charlotte Martin / Pierre Raia / Antoine Koehl / Toon Laeremans / Jan Steyaert / Aashish Manglik / Steven Ballet / Andreas Boland / Miriam Stoeber / Abstract: The μ-opioid receptor (μOR), a prototypical member of the G protein-coupled receptor (GPCR) family, is the molecular target of opioid analgesics such as morphine and fentanyl. Due to the ...The μ-opioid receptor (μOR), a prototypical member of the G protein-coupled receptor (GPCR) family, is the molecular target of opioid analgesics such as morphine and fentanyl. Due to the limitations and severe side effects of currently available opioid drugs, there is considerable interest in developing novel modulators of μOR function. Most GPCR ligands today are small molecules, however biologics, including antibodies and nanobodies, are emerging as alternative therapeutics with clear advantages such as affinity and target selectivity. Here, we describe the nanobody NbE, which selectively binds to the μOR and acts as an antagonist. We functionally characterize NbE as an extracellular and genetically encoded μOR ligand and uncover the molecular basis for μOR antagonism by solving the cryo-EM structure of the NbE-μOR complex. NbE displays a unique ligand binding mode and achieves μOR selectivity by interactions with the orthosteric pocket and extracellular receptor loops. Based on a β-hairpin loop formed by NbE that deeply inserts into the μOR and centers most binding contacts, we design short peptide analogues that retain μOR antagonism. The work illustrates the potential of nanobodies to uniquely engage with GPCRs and describes novel μOR ligands that can serve as a basis for therapeutic developments. | ||||||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_18541.map.gz | 108.8 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-18541-v30.xml emd-18541.xml | 36.6 KB 36.6 KB | Display Display | EMDB header |
Images | emd_18541.png | 29.5 KB | ||
Masks | emd_18541_msk_1.map | 125 MB | Mask map | |
Filedesc metadata | emd-18541.cif.gz | 7.6 KB | ||
Others | emd_18541_additional_1.map.gz emd_18541_additional_2.map.gz emd_18541_additional_3.map.gz emd_18541_additional_4.map.gz emd_18541_additional_5.map.gz emd_18541_half_map_1.map.gz emd_18541_half_map_2.map.gz | 62.8 MB 62.9 MB 109.4 MB 115.9 MB 115.9 MB 116.1 MB 116.1 MB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-18541 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-18541 | HTTPS FTP |
-Validation report
Summary document | emd_18541_validation.pdf.gz | 685.9 KB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_18541_full_validation.pdf.gz | 685.5 KB | Display | |
Data in XML | emd_18541_validation.xml.gz | 13.7 KB | Display | |
Data in CIF | emd_18541_validation.cif.gz | 16.2 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-18541 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-18541 | HTTPS FTP |
-Related structure data
Related structure data | 8qotMC M: atomic model generated by this map C: citing same article (ref.) |
---|---|
Similar structure data | Similarity search - Function & homologyF&H Search |
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|---|
Related items in Molecule of the Month |
-Map
File | Download / File: emd_18541.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | DeepEMhancer sharpened map of the MOR_NbE_NabFab_anti-Fab complex. | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.9759 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Mask #1
File | emd_18541_msk_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Unsharpened map of the MOR NbE NabFab anti-Fab complex.
File | emd_18541_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened map of the MOR_NbE_NabFab_anti-Fab complex. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Unsharpened MOR NbE map (focused refinement).
File | emd_18541_additional_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Unsharpened MOR_NbE map (focused refinement). | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: DeepEMhancer sharpened MOR NbE map (focused refinement).
File | emd_18541_additional_3.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | DeepEMhancer sharpened MOR_NbE map (focused refinement). | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Half map A of the MOR NbE map (focused refinement).
File | emd_18541_additional_4.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map A of the MOR_NbE map (focused refinement). | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: Half map B of the MOR NbE map (focused refinement).
File | emd_18541_additional_5.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map B of the MOR_NbE map (focused refinement). | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Half map A of the MOR NbE NabFab anti-Fab complex.
File | emd_18541_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map A of the MOR_NbE_NabFab_anti-Fab complex. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: Half map B of the MOR NbE NabFab anti-Fab complex.
File | emd_18541_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Half map B of the MOR_NbE_NabFab_anti-Fab complex. | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Sample components
-Entire : MOR-NbE-NabFab-AntiFab complex
Entire | Name: MOR-NbE-NabFab-AntiFab complex |
---|---|
Components |
|
-Supramolecule #1: MOR-NbE-NabFab-AntiFab complex
Supramolecule | Name: MOR-NbE-NabFab-AntiFab complex / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all Details: Mu-opioid receptor bound to a nanobody antagonist (NbE), and NabFab module used as fiducial marker. |
---|---|
Source (natural) | Organism: Mus musculus (house mouse) |
Molecular weight | Theoretical: 120 KDa |
-Macromolecule #1: Mu-type opioid receptor
Macromolecule | Name: Mu-type opioid receptor / type: protein_or_peptide / ID: 1 / Details: MOR-2xSTREP-8xHIS / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Mus musculus (house mouse) |
Molecular weight | Theoretical: 53.994215 KDa |
Recombinant expression | Organism: Spodoptera frugiperda (fall armyworm) |
Sequence | String: MKTIIALSYI FCLVFADYKD DDDAMGPGNI SDCSDPLAPA SCSPAPGSWL NLSHVDGNQS DPCGPNRTGL GENLYFQGSH SLCPQTGSP SMVTAITIMA LYSIVCVVGL FGNFLVMYVI VRYTKMKTAT NIYIFNLALA DALATSTLPF QSVNYLMGTW P FGNILCKI ...String: MKTIIALSYI FCLVFADYKD DDDAMGPGNI SDCSDPLAPA SCSPAPGSWL NLSHVDGNQS DPCGPNRTGL GENLYFQGSH SLCPQTGSP SMVTAITIMA LYSIVCVVGL FGNFLVMYVI VRYTKMKTAT NIYIFNLALA DALATSTLPF QSVNYLMGTW P FGNILCKI VISIDYYNMF TSIFTLCTMS VDRYIAVCHP VKALDFRTPR NAKIVNVCNW ILSSAIGLPV MFMATTKYRQ GS IDCTLTF SHPTWYWENL LKICVFIFAF IMPVLIITVC YGLMILRLKS VRMLSGSKEK DRNLRRITRM VLVVVAVFIV CWT PIHIYV IIKALITIPE TTFQTVSWHF CIALGYTNSC LNPVLYAFLD ENFKRCFREF CIPTSSTILE VLFQGPEQQN SARI RQNTR EHPSTANTVD RTNHQLENLE AETAPLPSSL AEENLYFQSW SHPQFEKGGG SGGGSGGGSW SHPQFEKGAH HHHHH HH UniProtKB: Mu-type opioid receptor |
-Macromolecule #2: Nanobody E (NbE)
Macromolecule | Name: Nanobody E (NbE) / type: protein_or_peptide / ID: 2 / Details: synthesized nanobody NbE-6xHis / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Lama glama (llama) |
Molecular weight | Theoretical: 18.458662 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: VKKLLFAIPL VVPFYAAQPA MAQVQLVESG GGLVQAGGSL RLSCAASGSI SSISTMGWYR QAPGKERELV AAITSGGSTN YADSVKGRF TISRDNAKNT VYLQMNSLKP EDTAVYYCNF KYYSGSYFYK SEYDYWGKGT PVTVSSAAAH HHHHHGAAEQ K LISEEDLN GAA |
-Macromolecule #3: NabFab HC
Macromolecule | Name: NabFab HC / type: protein_or_peptide / ID: 3 / Details: Signal sequence-NabFab HC / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: synthetic construct (others) |
Molecular weight | Theoretical: 28.220525 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: MKKNIAFLLA SMFVFSIATN AYAEISEVQL VESGGGLVQP GGSLRLSCAA SGFNFSYYSI HWVRQAPGKG LEWVAYISSS SSYTSYADS VKGRFTISAD TSKNTAYLQM NSLRAEDTAV YYCARGYQYW QYHASWYWNG GLDYWGQGTL VTVSSASTKG P SVFPLAPS ...String: MKKNIAFLLA SMFVFSIATN AYAEISEVQL VESGGGLVQP GGSLRLSCAA SGFNFSYYSI HWVRQAPGKG LEWVAYISSS SSYTSYADS VKGRFTISAD TSKNTAYLQM NSLRAEDTAV YYCARGYQYW QYHASWYWNG GLDYWGQGTL VTVSSASTKG P SVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VN HKPSNTK VDKKVEPKSC DKTHT |
-Macromolecule #4: NabFab LC
Macromolecule | Name: NabFab LC / type: protein_or_peptide / ID: 4 / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: synthetic construct (others) |
Molecular weight | Theoretical: 25.794859 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: MKKNIAFLLA SMFVFSIATN AYASDIQMTQ SPSSLSASVG DRVTITCRAS QSVSSAVAWY QQKPGKAPKL LIYSASSLYS GVPSRFSGS RSGTDFTLTI SSLQPEDFAT YYCQQSSSSL ITFGQGTKVE IKRTVAAPSV FIFPPSDSQL KSGTASVVCL L NNFYPREA ...String: MKKNIAFLLA SMFVFSIATN AYASDIQMTQ SPSSLSASVG DRVTITCRAS QSVSSAVAWY QQKPGKAPKL LIYSASSLYS GVPSRFSGS RSGTDFTLTI SSLQPEDFAT YYCQQSSSSL ITFGQGTKVE IKRTVAAPSV FIFPPSDSQL KSGTASVVCL L NNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC |
-Macromolecule #5: Anti-Fab Nanobody
Macromolecule | Name: Anti-Fab Nanobody / type: protein_or_peptide / ID: 5 / Details: Signal sequence-6xHis Anti-Fab nanobody / Number of copies: 1 / Enantiomer: LEVO |
---|---|
Source (natural) | Organism: Lama glama (llama) |
Molecular weight | Theoretical: 17.414383 KDa |
Recombinant expression | Organism: Escherichia coli (E. coli) |
Sequence | String: MKYLLPTAAA GLLLLAAQPA MAMHHHHHHG ENLYFQGSQV QLQESGGGLV QPGGSLRLSC AASGRTISRY AMSWFRQAPG KEREFVAVA RRSGDGAFYA DSVQGRFTVS RDDAKNTVYL QMNSLKPEDT AVYYCAIDSD TFYSGSYDYW GQGTQVTVSS |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Concentration | 2.8 mg/mL | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Buffer | pH: 7.5 Component:
| |||||||||||||||
Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Support film - Material: GOLD / Support film - topology: HOLEY / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 60 sec. / Pretreatment - Atmosphere: AIR | |||||||||||||||
Vitrification | Cryogen name: ETHANE / Chamber humidity: 95 % / Chamber temperature: 288 K / Instrument: LEICA EM GP | |||||||||||||||
Details | MOR receptor was expressed and purified in insect cells in isolation. NbE was expressed and purified in E. coli. NabFab module was expressed and purified in E. coli. All purified components were incubated and formed readily a stable complex. Final complex was purified over size exclusion chromatography. |
-Electron microscopy
Microscope | FEI TALOS ARCTICA |
---|---|
Temperature | Min: 90.0 K / Max: 95.0 K |
Image recording | Film or detector model: FEI FALCON III (4k x 4k) / Detector mode: COUNTING / Digitization - Dimensions - Width: 4096 pixel / Digitization - Dimensions - Height: 4096 pixel / Number grids imaged: 4 / Number real images: 5938 / Average exposure time: 52.0 sec. / Average electron dose: 40.0 e/Å2 |
Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
Electron optics | C2 aperture diameter: 70.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.6 µm / Nominal magnification: 150000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | Model: Talos Arctica / Image courtesy: FEI Company |
+Image processing
-Atomic model buiding 1
Initial model |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Space: REAL / Protocol: AB INITIO MODEL / Overall B value: 68 | ||||||||||
Output model | PDB-8qot: |